Physician profile
Eric H Thall
NPI 1225029572
$5,076.23
in general payments reported to CMS, 2019-2025
39 companies · $1,064 in 2025
The $1,064 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $779 · 2020: $238 · 2021: $579 · 2022: $728 · 2023: $978 · 2024: $709 · 2025: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,573 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,572.69 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $867.15 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $822.73 | 2019-2025 | Xtandi, Myrbetriq |
| Pfizer INC. | $423.48 | 2019-2025 | |
| Antares Pharma, INC. | $398.77 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Sumitomo Pharma America, INC. | $346.33 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $334.75 | 2019-2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $314.59 | 2019-2025 | |
| Verity Pharmaceuticals INC. | $218.84 | 2023-2025 | Trelstar |
| Boston Scientific Corporation | $185.80 | 2019-2023 | |
| Myovant Sciences INC. | $118.76 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $90.26 | 2022-2024 | Pylarify |
| Tolmar, INC. | $76.61 | 2024-2025 | Jatenzo |
| Coloplast Corp | $71.58 | 2019-2025 | |
| Accord Healthcare, INC. | $67.66 | 2023-2025 | |
| Halozyme INC | $62.48 | 2023 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Thall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.